Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO Post author:Sam Post published:November 13, 2017 Post category:BioPharma Denali plans to make a $100M IPO under the symbol DNLI. Source: BioSpace You Might Also Like Journalist Sues FDA for Documents Related to Sarepta's DMD Drug May 25, 2017 Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline May 31, 2017 New Study Indicates DNA Plays Role in Gender Identity March 18, 2018
